Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Clinicopathologic features and responses to radiotherapy of myeloid sarcoma.

Chen WY, Wang CW, Chang CH, Liu HH, Lan KH, Tang JL, Tien HF, Kuo SH, Cheng AL.

Radiat Oncol. 2013 Oct 22;8:245. doi: 10.1186/1748-717X-8-245.

2.

Clinicopathological, Cytogenetic, and Prognostic Analysis of 131 Myeloid Sarcoma Patients.

Kawamoto K, Miyoshi H, Yoshida N, Takizawa J, Sone H, Ohshima K.

Am J Surg Pathol. 2016 Nov;40(11):1473-1483.

PMID:
27631510
3.

Radiation therapy for chloroma (granulocytic sarcoma).

Bakst R, Wolden S, Yahalom J.

Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1816-22. doi: 10.1016/j.ijrobp.2011.02.057. Epub 2011 Sep 28.

4.

Myeloid sarcoma is associated with superior event-free survival and overall survival compared with acute myeloid leukemia.

Tsimberidou AM, Kantarjian HM, Wen S, Keating MJ, O'Brien S, Brandt M, Pierce S, Freireich EJ, Medeiros LJ, Estey E.

Cancer. 2008 Sep 15;113(6):1370-8. doi: 10.1002/cncr.23691.

5.

Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemia.

Jurlander J, Caligiuri MA, Ruutu T, Baer MR, Strout MP, Oberkircher AR, Hoffmann L, Ball ED, Frei-Lahr DA, Christiansen NP, Block AM, Knuutila S, Herzig GP, Bloomfield CD.

Blood. 1996 Sep 15;88(6):2183-91.

6.

Extramedullary tumors of myeloid blasts in adults as a pattern of relapse following allogeneic bone marrow transplantation.

Koc Y, Miller KB, Schenkein DP, Daoust P, Sprague K, Berkman E.

Cancer. 1999 Feb 1;85(3):608-15. Review.

PMID:
10091734
7.

Clinico-pathological characteristics of myeloid sarcoma at diagnosis and during follow-up: report of 12 cases from a single institution.

Breccia M, Mandelli F, Petti MC, D'Andrea M, Pescarmona E, Pileri SA, Carmosino I, Russo E, De Fabritiis P, Alimena G.

Leuk Res. 2004 Nov;28(11):1165-9. Review.

PMID:
15380340
8.

Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy.

Tsimberidou AM, Kantarjian HM, Estey E, Cortes JE, Verstovsek S, Faderl S, Thomas DA, Garcia-Manero G, Ferrajoli A, Manning JT, Keating MJ, Albitar M, O'Brien S, Giles FJ.

Leukemia. 2003 Jun;17(6):1100-3.

PMID:
12764375
9.

Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.

Ortega JJ, Díaz de Heredia C, Olivé T, Bastida P, Llort A, Armadans L, Torrabadella M, Massuet L.

Haematologica. 2003 Mar;88(3):290-9.

10.

Dose response and local control using radiotherapy in non-metastatic Ewing sarcoma.

Paulino AC, Nguyen TX, Mai WY, Teh BS, Wen BC.

Pediatr Blood Cancer. 2007 Aug;49(2):145-8.

PMID:
16732580
11.

Treosulfan, fludarabine, and 2-Gy total body irradiation followed by allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and acute myeloid leukemia.

Gyurkocza B, Gutman J, Nemecek ER, Bar M, Milano F, Ramakrishnan A, Scott B, Fang M, Wood B, Pagel JM, Baumgart J, Delaney C, Maziarz RT, Sandmaier BM, Estey EH, Appelbaum FR, Storer BE, Deeg HJ.

Biol Blood Marrow Transplant. 2014 Apr;20(4):549-55. doi: 10.1016/j.bbmt.2014.01.009. Epub 2014 Jan 16.

12.

Long-term outcomes of de novo acute myeloid leukemia in Thai patients.

Niparuck P, Chuncharunee S, Ungkanont A, Udomtrupayakul U, Aungchaisuksiri P, Rerkamnuatchoke B, Jootar S, Atichartakarn V.

J Med Assoc Thai. 2009 Sep;92(9):1143-9.

PMID:
19772172
13.

Clinicopathological and molecular features of myeloid sarcoma as initial presentation of therapy-related myeloid neoplasms: a single institution experience.

Peker D, Parekh V, Paluri R, Deal T, Borate U, Di Stasi A, Harada S, Arroyo EA, Reddy V.

Int J Hematol. 2014 Nov;100(5):457-63. doi: 10.1007/s12185-014-1659-y. Epub 2014 Sep 11.

PMID:
25209604
14.

Clinical implications of acute myeloid leukemia presenting as myeloid sarcoma.

Avni B, Rund D, Levin M, Grisariu S, Ben-Yehuda D, Bar-Cohen S, Paltiel O.

Hematol Oncol. 2012 Mar;30(1):34-40. doi: 10.1002/hon.994. Epub 2011 Jun 2.

PMID:
21638303
15.

Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort Study.

Granfeldt Østgård LS, Medeiros BC, Sengeløv H, Nørgaard M, Andersen MK, Dufva IH, Friis LS, Kjeldsen E, Marcher CW, Preiss B, Severinsen M, Nørgaard JM.

J Clin Oncol. 2015 Nov 1;33(31):3641-9. doi: 10.1200/JCO.2014.60.0890. Epub 2015 Aug 24.

PMID:
26304885
16.

Allogeneic hematopoietic stem-cell transplantation for myeloid sarcoma: a retrospective study from the SFGM-TC.

Chevallier P, Mohty M, Lioure B, Michel G, Contentin N, Deconinck E, Bordigoni P, Vernant JP, Hunault M, Vigouroux S, Blaise D, Tabrizi R, Buzyn A, Socie G, Michallet M, Volteau C, Harousseau JL.

J Clin Oncol. 2008 Oct 20;26(30):4940-3. doi: 10.1200/JCO.2007.15.6315. Epub 2008 Jul 7.

PMID:
18606981
17.

Cutaneous myeloid sarcoma: natural history and biology of an uncommon manifestation of acute myeloid leukemia.

Hurley MY, Ghahramani GK, Frisch S, Armbrecht ES, Lind AC, Nguyen TT, Hassan A, Kreisel FH, Frater JL.

Acta Derm Venereol. 2013 May;93(3):319-24. doi: 10.2340/00015555-1458.

18.

The effectiveness of radiotherapy for leukemia cutis.

Elsayad K, Oertel M, Haverkamp U, Eich HT.

J Cancer Res Clin Oncol. 2017 May;143(5):851-859. doi: 10.1007/s00432-016-2338-6. Epub 2017 Jan 16.

PMID:
28093639
19.

[Clinicopathologic and immunophenotypic analysis of myeloid sarcoma].

Li JM, Liu WP, Zhang MH, Wei X, Gu JM, Han AJ, Wu WQ, Chen XY.

Zhonghua Bing Li Xue Za Zhi. 2006 Oct;35(10):606-11. Chinese.

PMID:
17134569
20.

Treatment outcomes for patients with chloroma receiving radiation therapy.

Hall MD, Chen YJ, Schultheiss TE, Pezner RD, Stein AS, Wong JY.

J Med Imaging Radiat Oncol. 2014 Aug;58(4):523-7. doi: 10.1111/1754-9485.12172. Epub 2014 Mar 20.

PMID:
24649928

Supplemental Content

Support Center